P25711 NADH-ubiquinone oxidoreductase 21 kDa subunit, mitochondrial MolNFT, Molecular NFT on GenesisL1

NADH-ubiquinone oxidoreductase 21 kDa subunit, mitochondrial

MOLNFT AF v1 smart contract in GenesisL1 blockchain:

0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD

IPFS of NFT metadata:

bafybeievhs466le3cesb75qltaddctd7dqlhfhnunwdy3hv3ixabh6tjli/metadata.json

IPFS of structure file:

bafybeia5m7dapwufpeorg2nbq5oajye4t3dj4f3o36mfklhh5wlgttj67y/AF-P25711-F1-model_v2.pdb

First NFT owner address (eip-55):

0x02399DAD8BAfD11Be4a2f8CC40EC4A6C8116369F

First NFT owner address (bech32):

genesis1qguemtvt4lg3he9zlrxypmz2djq3vd5l8q6lwd

Current NFT ID #262726 owner (web3):

0xA528629DC5BcCeBDa9059C9f45aab2F210565E6f

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
262726
Accession (UniProt):
P25711
Name::
NADH-ubiquinone oxidoreductase 21 kDa subunit, mitochondrial
Experimental Method:
Predicted structure
Sequence source:
NEUROSPORA CRASSA (STRAIN ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT P25711 research and analysis (ICN3D with VR)

FASTA sequences

>sp|P25711|NDUS4_NEUCR NADH-ubiquinone oxidoreductase 21 kDa subunit, mitochondrial OS=Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) OX=367110 GN=nuo-21 PE=1 SV=2 MSALRITTASAARMLRTSNAMMPSVMGAAQRRALSDSAEPARVPSVESARVPEKLAKEDSPLATPKRNSPDYNVPIDKATSTWTPVPKHIQNGSEEGILPAAVVSGAPMELQARTVRIYLPSKPATQSSNSRVLWRMDWDVLEKGHRWENELMGWQSSGDFVQGTHLTFRTKEEAIQFAEKQGYEYFVQEPNQRHFTPKAYANNFLYSPKKLKIVRTK

P25711 AF NFT

MOLNFT AF v1

NFT data

MOLNFT P25711 research and analysis (ICN3D with VR)

FASTA sequences

We use cookies on this site to enhance your user experience